Cargando…
Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report
Nivolumab, a fully human IgG4 immune checkpoint inhibitor (ICI) antibody, has been approved for a variety of cancers. Several endocrine-associated immune-related adverse events have been reported, but the incidence rate is relatively low. This is a case of a patient with gastric cancer who underwent...
Autores principales: | Marshall, Shoko, Kizuki, Aki, Kitaoji, Tadashi, Imada, Hiroshi, Kato, Hayato, Hosoda, Mana, Ishikawa, Motonao, Sakura, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590777/ https://www.ncbi.nlm.nih.gov/pubmed/33173483 http://dx.doi.org/10.1159/000510044 |
Ejemplares similares
-
Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review
por: Zeng, Mei Fang, et al.
Publicado: (2017) -
Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review: Erratum
Publicado: (2018) -
Universal testing for SARS-CoV-2 infection on admission among hospitalized emergency patients: A survey report from a single facility in Tokyo
por: Marshall, Shoko, et al.
Publicado: (2022) -
A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency
por: Sato, Yozo, et al.
Publicado: (2019) -
Secondary spontaneous pneumothorax in a patient with resistant Mycobacterium abscessus infection and systemic sclerosis-associated interstitial lung disease: A case report
por: Nishizawa, Yoko, et al.
Publicado: (2023)